Swiss pharmaceutical giant Roche unveiled ambitious plans on Tuesday for a substantial $50 billion investment in the United States over the coming five years. This significant commitment represents ...

Danish drugmaker Novo Nordisk A/S (CPH: NOVO-B) lost more than 10% last week after its US rival Eli Lilly & Co (NYSE: LLY) reported encouraging Phase 3 data for its oral weight-loss treatment. ...